Immunic, Inc. Basic Shares Outstanding (Weighted Average)
Immunic, Inc. (IMUX) reported Basic Shares Outstanding (Weighted Average) of 42.51 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Immunic, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 42.51M shares, a 221.65% increase year-over-year.
- Immunic, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 30.14M shares, a 197.37% increase year-over-year.
- Immunic, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 194.32M shares, a 92.96% increase year-over-year.
- Immunic, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 193.90M shares, a 91.46% increase year-over-year.
- Immunic, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 155.69M shares, a 55.42% increase from fiscal 2024.
- Immunic, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 100.17M shares, a 126.03% increase from fiscal 2023.
- Immunic, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 44.32M shares, a 39.29% increase from fiscal 2022.
- Immunic, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 31.82M shares, a 34.53% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 42.51M shares 10-Q · filed 2026-08-11 | 36.36M shares 10-Q · filed 2026-08-11 | 88.99M shares derived: average of 3 quarters · filed 2026-08-11 | 115.22M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | 30.14M shares 10-Q · filed 2026-05-13 | 112.23M shares derived: average of 2 quarters · filed 2026-05-13 | 139.45M shares derived: average of 3 quarters · filed 2026-05-13 | 107.89M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | 194.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 194.11M shares derived: average of 2 quarters · filed 2026-02-26 | 133.81M shares derived: average of 3 quarters · filed 2026-08-11 | 155.69M shares 10-K · filed 2026-02-26 | ||
| 2025-09-30 | 193.90M shares 10-Q · filed 2025-11-13 | 103.56M shares derived: average of 2 quarters · filed 2026-08-11 | 142.81M shares 10-Q · filed 2025-11-13 | 79.49M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | 13.22M shares 10-Q · filed 2026-08-11 | 132.18M shares 10-Q · filed 2025-08-07 | 11.68M shares 10-Q · filed 2026-08-11 | 116.84M shares 10-Q · filed 2025-08-07 | 41.35M shares derived: average of 3 quarters · filed 2026-08-11 | 56.33M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 10.13M shares 10-Q · filed 2026-05-13 | 101.34M shares 10-Q · filed 2025-05-15 | 55.42M shares derived: average of 2 quarters · filed 2026-05-13 | 70.70M shares derived: average of 3 quarters · filed 2026-05-13 | 78.35M shares derived: average of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | 100.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 100.99M shares derived: average of 2 quarters · filed 2026-02-26 | 101.08M shares derived: average of 3 quarters · filed 2026-02-26 | 100.17M shares 10-K · filed 2026-02-26 | ||
| 2024-09-30 | 101.27M shares 10-Q · filed 2025-11-13 | 101.27M shares derived: average of 2 quarters · filed 2025-11-13 | 100.00M shares 10-Q · filed 2025-11-13 | 86.11M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 101.27M shares 10-Q · filed 2025-08-07 | 99.61M shares 10-Q · filed 2025-08-07 | 81.06M shares derived: average of 3 quarters · filed 2025-08-07 | 71.94M shares derived: average of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | 97.30M shares 10-Q · filed 2025-05-15 | 70.95M shares derived: average of 2 quarters · filed 2025-05-15 | 62.16M shares derived: average of 3 quarters · filed 2025-05-15 | 57.73M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 44.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 44.59M shares derived: average of 2 quarters · filed 2025-03-31 | 44.54M shares derived: average of 3 quarters · filed 2025-03-31 | 44.32M shares 10-K · filed 2025-03-31 | ||
| 2023-09-30 | 44.57M shares 10-Q · filed 2024-11-07 | 44.50M shares derived: average of 2 quarters · filed 2024-11-07 | 44.23M shares 10-Q · filed 2024-11-07 | 42.75M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 44.43M shares 10-Q · filed 2024-08-08 | 44.04M shares 10-Q · filed 2024-08-08 | 42.14M shares derived: average of 3 quarters · filed 2024-08-08 | 39.24M shares derived: average of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | 43.66M shares 10-Q · filed 2024-05-08 | 40.99M shares derived: average of 2 quarters · filed 2024-05-08 | 37.51M shares derived: average of 3 quarters · filed 2024-05-08 | 35.70M shares derived: average of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | 38.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 34.44M shares derived: average of 2 quarters · filed 2024-02-22 | 33.04M shares derived: average of 3 quarters · filed 2024-02-22 | 31.82M shares 10-K · filed 2024-02-22 | ||
| 2022-09-30 | 30.56M shares 10-Q · filed 2023-11-14 | 30.41M shares derived: average of 2 quarters · filed 2023-11-14 | 29.66M shares 10-Q · filed 2023-11-14 | 29.72M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 30.25M shares 10-Q · filed 2023-08-03 | 28.69M shares 10-Q · filed 2023-08-03 | 29.44M shares derived: average of 3 quarters · filed 2023-08-03 | 28.41M shares derived: average of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | 28.13M shares 10-Q · filed 2023-05-11 | 29.03M shares derived: average of 2 quarters · filed 2023-05-11 | 27.79M shares derived: average of 3 quarters · filed 2023-05-11 | 26.28M shares derived: average of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | 29.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 27.63M shares derived: average of 2 quarters · filed 2023-02-23 | 25.67M shares derived: average of 3 quarters · filed 2023-02-23 | 23.65M shares 10-K · filed 2023-02-23 | ||
| 2021-09-30 | 25.32M shares 10-Q · filed 2022-11-03 | 23.53M shares derived: average of 2 quarters · filed 2022-11-03 | 21.56M shares 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | 21.75M shares 10-Q · filed 2022-08-04 | 21.46M shares 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | 21.17M shares 10-Q · filed 2022-05-10 | |||||
| 2020-12-31 | 15.66M shares 10-K · filed 2022-02-24 | |||||
| 2019-03-31 | 42.37M shares 10-Q · filed 2019-04-10 | |||||
| 2018-03-31 | 42.37M shares 10-Q · filed 2019-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |